Correlation Between Recursion Pharmaceuticals and Fbec Worldwide

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Fbec Worldwide at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Fbec Worldwide into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and Fbec Worldwide, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Fbec Worldwide and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Fbec Worldwide. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Fbec Worldwide.

Diversification Opportunities for Recursion Pharmaceuticals and Fbec Worldwide

-0.09

Correlation Coefficient

Recursion Pharmaceuticals  Fbec Worldwide

Good diversification

The 3 months correlation between Recursion and Fbec is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Fbec Worldwide in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fbec Worldwide and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Fbec Worldwide. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fbec Worldwide has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Fbec Worldwide go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Fbec Worldwide

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 199.88 times less return on investment than Fbec Worldwide. But when comparing it to its historical volatility, Recursion Pharmaceuticals is 12.73 times less risky than Fbec Worldwide. It trades about 0.02 of its potential returns per unit of risk. Fbec Worldwide is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  0.05  in Fbec Worldwide on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Fbec Worldwide or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  Fbec Worldwide

Recursion Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Fbec Worldwide

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Fbec Worldwide are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Fbec Worldwide exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Recursion Pharmaceuticals and Fbec Worldwide

The main advantage of trading using opposite Recursion Pharmaceuticals and Fbec Worldwide positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Fbec Worldwide can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fbec Worldwide will offset losses from the drop in Fbec Worldwide's long position.

The idea behind Recursion Pharmaceuticals and Fbec Worldwide pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.